Tower Research Capital LLC (Trc) Emergent Bio Solutions Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,576 shares of EBS stock, worth $76,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,576
Previous 231
7075.76%
Holding current value
$76,581
Previous $1,000
15700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding EBS
# of Institutions
174Shares Held
36.5MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$14.8 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$9.88 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$9.07 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$7.11 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $230M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...